重度中性粒细胞性哮喘与血清IgE升高、口服激素依赖及IL-17/22表达相关
该横断面研究基于70例轻至重度哮喘患者支气管固有层嗜酸性/中性粒细胞计数进行炎症表型分类,发现中性粒细胞性哮喘患者疾病更重、ICS剂量更高、急性加重更多且FEV1/FVC可逆性更低;高中性粒细胞亚组血清IgE升高、多年生过敏原敏感、口服激素依赖及支气管黏膜CD4+和IL-17F+细胞增多。
要点
- 中性粒细胞性哮喘患者疾病严重度、ICS剂量和急性加重次数更高,FEV1/FVC可逆性更低。
- 高中性粒细胞亚组血清IgE升高、多年生过敏原敏感及口服激素依赖增加。
- 高支气管中性粒细胞增多可能区分一种新的哮喘内型。
核心结论
- 高支气管中性粒细胞增多与过敏(IgE)及IL-17/22细胞因子表达相关的适应性免疫反应有关。
- 高支气管中性粒细胞增多可能区分一种新的哮喘内型。
研究设计与样本
- 横断面研究,纳入70例轻至重度哮喘患者,基于支气管固有层嗜酸性/中性粒细胞计数分类。
- 中性粒细胞性哮喘中性粒细胞计数截断值为47.17 neutrophils·mm-2,范围47.17-198.11 neutrophils·mm-2,中位数94.34 neutrophils·mm-2。
- 高中性粒细胞亚组定义为≥94.34 neutrophils·mm-2,中间组为47.17-<94.34 neutrophils·mm-2。
主要发现
- 中性粒细胞性哮喘患者(n=38;36例混合嗜酸性/中性粒细胞性)较非中性粒细胞性哮喘患者(n=32;28例嗜酸性及4例寡粒细胞性)疾病严重度、功能残气量、ICS剂量和急性加重更高,FVC%pred和FEV1可逆性更低。
- 中性粒细胞性哮喘患者支气管CD8+、IL-17-F+和IL-22+细胞增加,肥大细胞减少,嗜酸性粒细胞计数相似。
- FEV1和FVC可逆性是本队列支气管中性粒细胞增多的独立预测因子。
- 高中性粒细胞患者(n=21)血清IgE水平、多年生过敏原敏感性、急性加重率、口服糖皮质激素依赖及支气管黏膜CD4+和IL-17F+细胞增加。
- 排除吸烟者后,高中性粒细胞患者IL-17A+和IL-22+细胞增加。
关键数值与推荐
- 中性粒细胞性哮喘判定截断值:支气管固有层中性粒细胞计数47.17 neutrophils·mm-2。
- 高中性粒细胞亚组判定阈值:≥94.34 neutrophils·mm-2。
- 吸烟影响评估条件:吸烟≥10包年。
临床怎么用
- 对哮喘患者评估支气管中性粒细胞增多可能有助于识别疾病更重、ICS剂量更高且急性加重更多的表型。
- 高支气管中性粒细胞增多伴血清IgE升高和口服激素依赖提示需关注过敏及IL-17/22相关通路。
- FEV1和FVC可逆性可作为支气管中性粒细胞增多的预测参考。
局限性
- 研究为横断面设计,样本量70例,结果需进一步验证。
- 原文未报告多因素校正、随访时长及外部验证队列。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Information on the clinical traits associated with bronchial neutrophilia in asthma is scant, preventing its recognition and adequate treatment. We aimed to assess the clinical, functional and biological features of neutrophilic asthma and identify possible predictors of bronchial neutrophilia.The inflammatory phenotype of 70 mild-to-severe asthma patients was studied cross-sectionally based on the eosinophilic/neutrophilic counts in their bronchial lamina propria. Patients were classified as neutrophilic or non-neutrophilic. Neutrophilic asthma patients (neutrophil count cut-off: 47.17 neutrophils·mm-2; range: 47.17-198.11 neutrophils·mm-2; median: 94.34 neutrophils·mm-2) were further classified as high (≥94.34 neutrophils·mm-2) or intermediate (47.17- <94.34 neutrophils·mm-2). The effect of smoking ≥10 pack-years was also assessed.Neutrophilic asthma patients (n=38; 36 mixed eosinophilic/neutrophilic) had greater disease severity, functional residual capacity, inhaled corticosteroid (ICS) dose and exacerbations, and lower forced vital capacity (FVC) % pred and forced expiratory volume in 1 s (FEV1) reversibility than non-neutrophilic asthma patients (n=32; 28 eosinophilic and four paucigranulocytic). Neutrophilic asthma patients had similar eosinophil counts, increased bronchial CD8+, interleukin (IL)-17-F+ and IL-22+ cells, and decreased mast cells compared with non-neutrophilic asthma patients. FEV1 and FVC reversibility were independent predictors of bronchial neutrophilia in our cohort. High neutrophilic patients (n=21) had increased serum IgE levels, sensitivity to perennial allergens, exacerbation rate, oral corticosteroid dependence, and CD4+ and IL-17F+ cells in their bronchial mucosa. Excluding smokers revealed increased IL-17A+ and IL-22+ cells in highly neutrophilic patients.We provide new evidence linking the presence of high bronchial neutrophilia in asthma to an adaptive immune response associated with allergy (IgE) and IL-17/22 cytokine expression. High bronchial neutrophilia may discriminate a new endotype of asthma. Further research is warranted on the relationship between bronchoreversibility and bronchial neutrophilia.
引用
- Bullone M, Carriero V, Bertolini F, et al. Elevated serum IgE, oral corticosteroid dependence and IL-17/22 expression in highly neutrophilic asthma. Eur Respir J. 2019. PMID: 31439682. doi:10.1183/13993003.00068-2019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。